Relationship between pre-sarcopenia and quality of life in patients with chronic liver disease: a cross-sectional study.

AIM: This study aimed to clarify the relationship between pre-sarcopenia (PS) and quality of life (QOL) in patients with chronic liver disease (CLD). PATIENTS AND METHODS: This cross-sectional study evaluated 335 patients with CLD. PS was diagnosed on the basis of the assessment criteria by the Japan Society of Hepatology. QOL was evaluated using the short form-36. RESULTS: Patients' mean age was 69.52 ± 10.17 years, and 169 (50.4%) participants were men. The prevalence of PS was 53.7%. Patients were divided into the PS and non-pre-sarcopenia (NPS) groups. Patients in the PS group were older (71.84 ± 9.78 vs. 66.81 ± 9.97, P < 0.01) and mostly women (65.2 vs. 37.8%, P < 0.01) compared with those in the NPS group. QOL, physical function (38.30 ± 17.63 vs. 44.02 ± 14.76, P < 0.01), physical role functioning (RP) (40.63 ± 15.38 vs. 44.88 ± 13.89, P < 0.01), and bodily pain (BP) (48.42 ± 11.45 vs. 51.24 ± 10.19, P = 0.02) were significantly lower in the PS group than in the NPS group. Logistic regression analyses identified that the independent predictive factors for PS were female sex (odds ratio: 3.16, 95% confidence interval: 2.01-4.98; P < 0.01) and RP (odds ratio: 1.97, 95% confidence interval: 1.24-3.12; P < 0.01). CONCLUSION: QOL characteristics of PS patients with CLD were low physical function, RP, and BP in short form-36. In addition, social role functioning was low in the PS patients aged 65-74 years, whereas RP and BP were low in those aged at least 75 years. Female sex and RP were independent predictors of PS according to the multivariate analysis. Maintaining and increasing muscle mass in patients with CLD may contribute toward improving physical QOL.

Health-related quality of life on the clinical course of patients with chronic hepatitis C receiving daclatasvir/asunaprevir therapy: A prospective observational study comparing younger (<70) and elderly (≥70) patients.

Interferon-free direct acting antiviral agent regimens for chronic hepatitis C (CHC) have been developed. These regimens have shown a high rate of sustained virologic response (SVR), and a reduction in side effects during treatment is also anticipated. However, the impact of the regimens on health-related quality of life (HRQOL) and side effects during treatment is not fully understood. The purpose of the present study was to evaluate HRQOL in the clinical course of patients with CHC receiving daclatasvir/asunaprevir (DCV/ASV) therapy using the Short Form-36 (SF-36) method. Twenty-eight patients with CHC receiving DCV/ASV therapy were analyzed in the present study, and HRQOL was measured by SF-36. Patients were asked to fill out the SF-36 prior to therapy (baseline), following 12 weeks of therapy, at the end of treatment and at SVR week 24 (SVR24) to evaluate HRQOL. Laboratory data were also investigated during the same period, and associations between these results and SF-36 were investigated. Aspartate aminotransferase, alanine aminotransferase, serum albumin, α-fetoprotein, platelet counts and Fibrosis (Fib)-4 index were all significantly improved at each time point when compared with baseline. With regard to alterations in HRQOL during therapy, the ≥70-year-old group displayed a significantly greater improvement in physical functioning during the period between baseline and 12 weeks when compared with the <70-year-old group. In the analysis of the SF-36 differences within each group, general health improved significantly in the ≥70-year-old group, as well as albumin levels. In addition, Fib-4-index significantly improved at all time points (12 and 24 weeks, and SVR24) when compared with baseline in the ≥70-year-old group. Therefore, DCV/ASV therapy may improve HRQOL and hepatic functional reserve, particularly in elderly patients.

Reduction Method of Operator and Medical Staff Radiation Exposure in Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.

The purpose of this study is to investigate a reduction method of radiation exposure for operator and medical staff in balloon pulmonary angioplasty (BPA) for chronic thromboembolic pulmonary hypertension (CTEPH). We devised a new radiation protection, which is U-shaped acrylic supporting table with 0.35 mmPb unleaded radiation protection sheet. A human phantom was put on the bed of cardiac angiography system [C-arm angulation: posteroanterior (PA), L-arm angulation: left anterior oblique (LAO) 60°]. The ambient equivalent dose rate was measured under fluoroscopy with and without three radiation protections: U-shaped acrylic supporting table with 0.35 mmPb unleaded radiation protection sheet, radiation protection for the lower body, and radiation protection for the upper body. With the three radiation protections, the ambient equivalent dose rate was decreased more than 99% at the height of 100 cm above the floor at the operator position (PA: from 186.2 µSv/h to 0.5 µSv/h, LAO 60°: from 350.4 µSv/h to 1.6 µSv/h). Ambient equivalent dose rate at the other points are also decreased effectively. The devised dose reduction method can reduce operator and medical staff radiation exposure effectively and be set up without interference for BPA procedure.

Spatial and temporal changes in zooplankton abundance, biovolume, and size spectra in the neighboring waters of Japan: analyses using an optical plankton counter.

BACKGROUND: An optical plankton counter (OPC) was used to examine spatial and temporal changes in the zooplankton size spectra in the neighboring waters of Japan from May to August 2011. RESULTS: Based on the zooplankton biovolume of equivalent spherical diameter (ESD) in 45 bins for every 0.1 mm between0.5 and 5.0 mm, a Bray-Curtis cluster analysis classified the zooplankton communities into six groups. Thegeographical distribution of each group varied from each of the others. Groups with a dominance of 4 to 5 mm ESD were observed in northern marginal seas (northern Japan Sea and Okhotsk Sea), while the least biovolume with a dominance of a small-size class (0.5 to 1 mm) was observed for the Kuroshio extension. Temporal changes were observed along the 155° E line, i.e., a high biovolume group dominated by 2 to 3 mm ESD during May shifted to other size spectra groups during July to August. These temporal changes were caused by the seasonal vertical descent of dominant large Neocalanus copepods during July to August. As a specific characteristic of the normalized biomass size spectra (NBSS), the slope of NBSS was moderate (-0.90) for the Neocalanus dominant spring group but was at -1.11 to -1.24 for the other groups. Theoretically, the slope of the NBSS of the stable marine ecosystem is known to settle at approximately -1. CONCLUSIONS: Based on the analysis by OPC, zooplankton size spectra in the neighboring waters of Japan were separated into six groups. Most groups had -1.11 to -1.24 NBSS slopes, which were slightly higher than the theoretical value (-1). However, one group had a moderate slope of NBSS (-0.90) caused by the dominance of large Neocalanuscopepods.